Urothelial cancer
51 – 60 of 98
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
When the Molecular Subtype Is Hidden Behind a Veil of Stroma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tumor Subtyping : Making Sense of Heterogeneity with a Goal Toward Treatment
(
- Contribution to journal › Scientific review
-
Mark
multiclassPairs: An R package to train multiclass pair-based classifier
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Personalized medicine for bladder cancer
(
- Contribution to journal › Article
-
Mark
Association Between Estrogen Receptors and GATA3 in Bladder Cancer : A Systematic Review and Meta-Analysis of Their Clinicopathological Significance
(
- Contribution to journal › Scientific review
-
Mark
Urinary diversions for benign and oncologic indications: what did we learn about short term complications in the last 24 months?
(
- Contribution to journal › Article
-
Mark
Outcomes Following Exenteration for Gynecological Neoplasms
2021) p.265-282(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight
(
- Contribution to journal › Article
- 2020
-
Mark
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
(
- Contribution to journal › Article
-
Mark
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
(
- Contribution to journal › Article